Drug intelligence / Profile preview

cefazolin + ketorolac + pantoprazole + paracetamol

Development stage
Unknown
Lead developer
Hospital da Luz
Modality
Small Molecules
Administration
Intravenous
01

Overview

This standardized perioperative medication regimen is utilized by Hospital da Luz, Portugal, as a baseline treatment for patients undergoing orthopedic surgery with neuraxial anesthesia. The combination therapy consists of four distinct pharmaceutical agents: cefazolin, a first-generation cephalosporin antibiotic used for surgical site infection prophylaxis; ketorolac, a potent non-steroidal anti-inflammatory drug (NSAID) for acute pain management; pantoprazole, a proton pump inhibitor (PPI) administered to prevent stress-induced gastric ulcers and reduce acid secretion; and paracetamol, a non-opioid analgesic and antipyretic. In the context of clinical research (NCT04441411), this regimen is administered to all study participants to ensure a consistent baseline of care while evaluating the comparative effects of midazolam versus propofol sedation on core temperature variations.

Other names
Standard-Hospital da Luz, Portugal-procedural sedationStandard medication regimen (Hospital da Luz)Standard treatment (NCT04441411)
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ATP4A (Potassium–transporting ATPase alpha chain 1)PGHS-1 (Prostaglandin G/H Synthase 1)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefazolin + ketorolac + pantoprazole + paracetamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefazolin + ketorolac + pantoprazole + paracetamol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call